Mitoxantrone, prednisone, pentostatin and bleomycin for patients with indolent non-Hodgkin's lymphoma relapsed or unresponsive to previous treatments. Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (GISL)

Massimo Federico, Maura Brugiatelli, Romano Danesi et al.|IRIS UNIMORE (University of Modena and Reggio Emilia)|2003

Cited by 2